CM
UTHR icon

Caption Management’s United Therapeutics UTHR Stock Holding History

Caption Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.1M Buy
74,445
+19,364
+35% +$9.64M 0.26% 75
2025
Q4 		$26.8M Buy
55,081
+15,562
+39% +$7.25M 0.18% 122
2025
Q3 		$16.6M Buy
39,519
+21,319
+117% +$7.17M 0.13% 173
2025
Q2 		$5.23M Buy
18,200
+16,981
+1,393% +$5.07M 0.06% 392
2025
Q1 		$376K Buy
+1,219
New +$418K ﹤0.01% 1165
2022
Q4 		– Sell
-5,000
Closed -$1.05M – 1744
2022
Q3 		$1.05M Buy
+5,000
New +$1.12M 0.01% 854
2021
Q4 		– Sell
-25,937
Closed -$5.09M – 1954
2021
Q3 		$4.79M Buy
+25,937
New +$5.11M 0.05% 477

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Caption Management's UTHR Position: Q1 2026 in Review

Caption Management increased its United Therapeutics (UTHR) stake by 35% in Q1 2026, buying an estimated $9.64M and bringing the position to 74,445 shares worth $44.1M. The position accounts for 0.26% of the portfolio, ranked #75.

Caption Management first reported a position in UTHR in Q3 2021 and has held it in 7 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Caption Management held 74,445 shares of United Therapeutics worth $44.1M as of Q1 2026.
  • Caption Management bought 19,364 United Therapeutics shares in Q1 2026, an estimated $9.64M.
  • United Therapeutics made up 0.26% of Caption Management's portfolio in Q1 2026, its #75 holding.
  • Caption Management first reported a position in United Therapeutics in Q3 2021 and has held it in 7 quarters since.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.